Xencor | XNCR - أصول متداولة





أصول متداولة تغيير تاريخ
AbbVie USD 33.67B 140M 2026-06
Alnylam Pharmaceuticals USD 5.11B 492.49M 2026-09
Amgen USD 34.96B 3.49B 2026-06
Arrowhead Research USD 1.67B 168.34M 2026-06
AstraZeneca USD 27.97B 1.65B 2026-06
Biogen USD 7.58B 278.7M 2026-09
Bristol-Myers Squibb USD 29.77B 1.19B 2026-09
Cytokinetics USD 1.21B 369.02M 2026-06
GlaxoSmithKline GBP 17.9B 336M 2026-09
J&J USD 56.35B 3.42B 2026-09
Karyopharm Therapeutics USD 126.33M 23.19M 2026-03
MacroGenics USD 321.69M 139.16M 2026-06
Merck USD 36.68B 1.66B 2026-06
Novartis USD 27.35B 744M 2026-06
Pfizer USD 41.36B 1.46B 2026-06
Regeneron Pharmaceuticals USD 20.8B 2.35B 2026-09
Roche Holding CHF 35.44B 3.29B 2026-06
Xencor USD 523.21M 40.36M 2026-06